(Q39622438)

13 September 2017

title

Increasing the antitumor efficacy of doxorubicin-loaded liposomes with peptides anchored via a chelator lipid (English)

1 reference

13 September 2017

Thomas P Herringson

1

1 reference

13 September 2017

Joseph G Altin

series ordinal

2

1 reference

13 September 2017

publication date

9 December 2010

1 reference

Journal of Drug Targeting

13 September 2017

published in

1 reference

13 September 2017

volume

19

1 reference

13 September 2017

issue

8

1 reference

13 September 2017

page(s)

681-689

1 reference

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

A tumor cord model for doxorubicin delivery and dose optimization in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

Convenient targeting of stealth siRNA-lipoplexes to cells with chelator lipid-anchored molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

Targeting of plasmid DNA-lipoplexes to cells with molecules anchored via a metal chelator lipid.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

Human tumor necrosis factor-alpha mutant RGD-V29 (F4614) shows potent antitumor activity and reduced toxicity against human tumor xenografted nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

Homing peptides as targeted delivery vehicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

Targeted delivery of doxorubicin using stealth liposomes modified with transferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

Targeting tumor angiogenic vasculature using polymer-RGD conjugates.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

90Y and 111In complexes of a DOTA-conjugated integrin alpha v beta 3 receptor antagonist: different but biologically equivalent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

Pegylated liposomal Doxorubicin: a review of its use in the treatment of relapsed or refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

[(186)Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

Rac and Rho driving tumor invasion: who's at the wheel?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

Role of pegylated liposomal doxorubicin in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

21 January 2018

Ethics in nanomedicine

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.536984

10.3109/1061186X.2010.536984

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference